These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4058909)

  • 1. [The role of transurethral resection as a safety measure in the management of patients with bladder tumors].
    Kolozsy Z; Mohácsi L; Dauda G
    Orv Hetil; 1985 Oct; 126(42):2593-5. PubMed ID: 4058909
    [No Abstract]   [Full Text] [Related]  

  • 2. The value of a second transurethral resection in evaluating patients with bladder tumors.
    Herr HW
    J Urol; 1999 Jul; 162(1):74-6. PubMed ID: 10379743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transurethral resection for muscle-invasive bladder cancer.
    Kondás J; Váczi L; Szecsó L; Kondér G
    Int Urol Nephrol; 1993; 25(6):557-63. PubMed ID: 8175277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug prevention of recurrence in bladder tumors. Intravesical adriblastin instillation following transurethral resection of non-infiltrating bladder tumors].
    Maier U; Kuber W
    Fortschr Med; 1983 Mar; 101(12):535-40. PubMed ID: 6852720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.
    Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S
    J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A re-staging transurethral resection predicts early progression of superficial bladder cancer.
    Herr HW; Donat SM
    BJU Int; 2006 Jun; 97(6):1194-8. PubMed ID: 16566813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of low grade papillary bladder tumors.
    Herr HW; Donat SM; Reuter VE
    J Urol; 2007 Oct; 178(4 Pt 1):1201-5; discussion 1205. PubMed ID: 17698090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results.
    Ugurlu O; Gonulalan U; Adsan O; Kosan M; Oztekin V; Cetinkaya M
    Urology; 2007 Jul; 70(1):55-9. PubMed ID: 17656208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant BCG immunotherapy in the management of superficial bladder tumors].
    Somogyi L; Szántó A; Polyák L; Baranyay F; Drinóczy M
    Orv Hetil; 1993 Aug; 134(34):1851-6. PubMed ID: 8355975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.
    Al-Ali MA; Kashmoula DM; Haddad LF
    Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring.
    Nieder AM; Sved PD; Gomez P; Kim SS; Manoharan M; Soloway MS
    Urology; 2004 Nov; 64(5):950-4. PubMed ID: 15533484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Witjes JA
    Eur Urol; 2009 Apr; 55(4):919. PubMed ID: 18722044
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Herr HW
    Eur Urol; 2009 Apr; 55(4):920-1. PubMed ID: 18722043
    [No Abstract]   [Full Text] [Related]  

  • 16. The value of a second transurethral resection for T1 bladder cancer.
    Schwaibold HE; Sivalingam S; May F; Hartung R
    BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?
    Brauers A; Buettner R; Jakse G
    J Urol; 2001 Mar; 165(3):808-10. PubMed ID: 11176474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumor.
    Herr HW
    Semin Urol Oncol; 1997 Aug; 15(3):142-6. PubMed ID: 9394908
    [No Abstract]   [Full Text] [Related]  

  • 19. [Natural history and prognostic factors of superficial tumors of the bladder].
    Hoznek A; Bellot J; Abbou CC; Chopin DK
    Ann Urol (Paris); 1993; 27(1):20-3. PubMed ID: 8470875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.